International Journal of Health and Pharmaceutical Medicine, 2020, 1(4); doi: 10.38007/IJHPM.2020.010401.
Shanghai University of International Business and Economics, Shanghai, China
In recent years, the incidence rate of chronic liver disease is on the rise, and has become a global disease. Chronic liver disease is caused by long-term chronic liver injury, which will gradually develop into liver fibrosis, and severe liver fibrosis will lead to liver cirrhosis. The purpose of this study is to study the metabolic disorder of amino acids in chronic liver disease and the progress of branched chain amino acid therapy. This paper mainly introduces the disorder of amino acid metabolism and branched chain amino acids in chronic liver disease, and then collects the patients with chronic liver disease admitted to the Department of Gastroenterology of our hospital from January 2019 to December 2019. The patients were randomly divided into two groups: one group of ordinary treatment group, one group of branched chain amino acid treatment group, the general treatment group was treated with water-soluble vitamin liver protection, and the branched chain amino acid group was treated with intravenous drip column of 300ml branched chain amino acid. Then the clinical symptoms and signs, liver function, albumin and cytokines of the two groups were compared and analyzed before and after treatment. The results showed that: the clinical symptoms and signs, liver function, albumin and cytokines were significantly improved in the common group and BCAA group. Compared with the normal group, BCAA group increased appetite and edema of lower limbs by 15% and 47% respectively. The effect of BCAA on IGF-I and cytokine levels was better than that of water-soluble vitamin. Therefore, the effect of branched chain amino acids in the treatment of chronic liver disease is far better than that with water-soluble vitamins.
Chronic Liver Disease, Branched Chain Amino Acids, Liver Function, Cytokines
Yehua Wang. Metabolic Disorder of Amino Acids in Chronic Liver Disease and Progress in Treatment of Branched Chain Amino Acids. International Journal of Health and Pharmaceutical Medicine (2020), Vol. 1, Issue 4: 1-12. https://doi.org/10.38007/IJHPM.2020.010401.
 Fukuda R, Ishimura N, Niigaki M, et al.( 2015).“ Serologically silent hepatitis B virus coinfection in patients with hepatitis C virus-associated chronic liver disease: clinical and virological significance”. Journal of Medical Virology, 58(3), pp. 201-207. DOI: 10.1002/(SICI) 1096-9071(199907)58:3<201::AID-JMV3>3.0.CO;2-2
 Tsuda F, Hadiwandowo S, Sawada N, et al. (2015). “Infection with GB virus C (GBV-C) in patients with chronic liver disease or on maintenance hemodialysis in Indonesia”. Journal of Medical Virology, 49(3), pp. 248-252. DOI: 10.1002/(SICI)1096-9071(199607)49: 3<248:: AID -JMV15>3.0.CO;2-8
 Pant C, Jani B S, Desai M, et al. (2016)“Hepatorenal syndrome in hospitalized patients with chronic liver disease: results from the Nationwide Inpatient Sample 2002-2012”. Journal of Investigative Medicine the Official Publication of the American Federation for Clinical Research, 64(1), pp. 33. DOI: 10.1136/jim-d-15-00181
 Patrícia dos Santos Marcon, Tovo C V, Kliemann D A, et al.(2018).“ Incidence of hepatocellular carcinoma in patients with chronic liver disease due to hepatitis B or C and coinfected with the human immunodeficiency virus: A retrospective cohort study”. World Journal of Gastroenterology,, 24(5),pp.613-622. DOI: 10.3748/wjg.v24.i5.613
 Ren M, Zhang S, Liu X, et al.(2016).“ Different Lipopolysaccharide Branched-Chain Amino Acids Modulate Porcine Intestinal Endogenous β-Defensin Expression through the Sirt1/ERK/90RSK Pathway”. Journal of Agricultural & Food Chemistry, 64(17),pp. 3371. DOI: 10.1021/acs.jafc.6b00968
 Chen I F, Wu H J, Chen C Y, et al.(2016). “Branched-chain amino acids, arginine, citrulline alleviate central fatigue after 3 simulated matches in taekwondo athletes: a randomized controlled trial”. Journal of the International Society of Sports Nutrition, 13(1),pp.28.
 Hole?ek, Milan. Branched-chain.(2018).“ amino acids in health and disease: metabolism, alterations in blood plasma, and as supplements”. Nutrition & Metabolism, 15(1),pp.33.
 Sun H, Olson K C, Gao C, et al. (2016). “Catabolic Defect of Branched-Chain Amino Acids Promotes Heart Failure”. Circulation, 133(21), pp. 2038-2049. DOI: 10.1161/ CIRCULATIONAHA.115.020226
 Giesbertz P, Daniel H. (2016). “Branched-chain amino acids as biomarkers in diabetes”. Current Opinion in Clinical Nutrition & Metabolic Care, 2016, 19(1),pp. 48.
 Woo H I, Chun M R, Yang J S, et al.(2015).“ Plasma Amino Acid Profiling in Major Depressive Disorder Treated With Selective Serotonin Reuptake Inhibitors”. Cns Neuroence & Therapeutics, 21(5),pp. 417-424. DOI: 10.1111/cns.12372
 Melnikova N I, Kartseva E V, Kirsanov A S, et al.(2015).“ The Difficulty in Diagnosing of Rare Forms of Congenital Disorders of Amino Acid Metabolism in Infants (Hereditary Tyrosinemia”. Anesteziologiia I Reanimatologiia, 60(3),pp. 16-19.
 Grünert Sarah Catharina, Stefanie R F, Anke S, et al.(2018)“ Successful pregnancy in maple syrup urine disease: a case report and review of the literature”. Nutrition Journal,17(1),pp.51. DOI: 10.1186/s12937-018-0357-7